sivelestat has been researched along with acetylcysteine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Bhattacharya, K; Khatua, B; Mandal, C | 1 |
Azuma, A; Bando, M; Date, H; Ebina, M; Fukuoka, J; Gemma, A; Goto, Y; Hasegawa, Y; Hattori, N; Homma, S; Inase, N; Inoue, Y; Ishii, Y; Izumi, S; Johkoh, T; Kido, T; Kishaba, T; Kishi, K; Miyamoto, A; Mukae, H; Nakayama, T; Nishioka, Y; Ogura, T; Sakamoto, S; Sasaki, S; Suda, T; Sugino, K; Taguchi, Y; Takahashi, H; Takahashi, K; Taniguchi, H; Watanabe, K; Yokoyama, A; Yoshino, I | 1 |
Colle, I; Debacker, PJ; Devisscher, L; Geerts, A; Lefere, S; Raevens, S; Van Campenhout, S; Van Vlierberghe, H; Verhelst, X | 1 |
Becker, C; Benoliel, JJ; Elbim, C; Frère, C; Hémadi, M; Laforge, M; Massaad, C; Nuss, P | 1 |
1 review(s) available for sivelestat and acetylcysteine
Article | Year |
---|---|
Japanese guideline for the treatment of idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Disease Progression; Drug Therapy, Combination; Evidence-Based Medicine; Glycine; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Indoles; Japan; Lung Neoplasms; Meta-Analysis as Topic; Practice Guidelines as Topic; Prognosis; Pyridones; Quality of Health Care; Sulfonamides; Survival Rate | 2018 |
4 other study(ies) available for sivelestat and acetylcysteine
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Sialoglycoproteins adsorbed by Pseudomonas aeruginosa facilitate their survival by impeding neutrophil extracellular trap through siglec-9.
Topics: Acetylcysteine; Adult; Animals; Antigens, CD; Cell Line; CHO Cells; Cricetinae; Cricetulus; Female; Free Radical Scavengers; Glycine; Humans; Immune Evasion; Immunity, Innate; Lectins; Leukosialin; Male; Neutrophils; Phagocytosis; Pseudomonas aeruginosa; Pseudomonas Infections; Reactive Oxygen Species; Serine Proteinase Inhibitors; Sialic Acid Binding Immunoglobulin-like Lectins; Sulfonamides | 2012 |
Combination of sivelestat and N-acetylcysteine alleviates the inflammatory response and exceeds standard treatment for acetaminophen-induced liver injury.
Topics: Acetaminophen; Acetylcysteine; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Free Radical Scavengers; Glycine; Inflammation; Male; Mice; Mice, Inbred C57BL; Serine Proteinase Inhibitors; Sulfonamides | 2020 |
Tissue damage from neutrophil-induced oxidative stress in COVID-19.
Topics: Acetylcysteine; Antioxidants; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Drug Therapy, Combination; Extracellular Traps; Gene Expression Regulation; Glycine; Host-Pathogen Interactions; Humans; Immunity, Innate; Lung; Lymphocytes; Neutrophils; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Pandemics; Pneumonia, Viral; Proteinase Inhibitory Proteins, Secretory; Reactive Oxygen Species; SARS-CoV-2; Severity of Illness Index; Sulfonamides; Superoxide Dismutase | 2020 |